XTX Topco Ltd Boosts Holdings in HCA Healthcare, Inc. (NYSE:HCA)

XTX Topco Ltd lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 273.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,611 shares of the company’s stock after purchasing an additional 7,766 shares during the quarter. XTX Topco Ltd’s holdings in HCA Healthcare were worth $3,409,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Bangor Savings Bank boosted its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the second quarter valued at $27,000. Unique Wealth Strategies LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC raised its stake in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. purchased a new stake in HCA Healthcare in the first quarter valued at approximately $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.6 %

Shares of NYSE:HCA opened at $399.89 on Thursday. The firm has a 50 day simple moving average of $367.24 and a 200-day simple moving average of $339.56. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $404.90. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a market capitalization of $104.74 billion, a PE ratio of 19.93, a P/E/G ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the business posted $4.29 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.66%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock valued at $6,407,273 in the last ninety days. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HCA. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective for the company. UBS Group boosted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Finally, Barclays upped their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.